The MURDOCK Study: A long-term initiative for disease reclassification through advanced biomarker discovery and integration with electronic health records

American Journal of Translational Research

Volumn 4, Issue 3, 2012, Pages 291-301

  Tenenbaum, Jessica D ^a   Christian, Victoria ^a   Cornish, Melissa A ^a   Dolor, Rowena J ^b   Dunham, Ashley A ^a   Ginsburg, Geoffrey S ^c   Kraus, Virginia B ^b   McHutchison, John G ^d   Nahm, Meredith L ^a   Kristin Newby, L ^e   Svetkey, Laura P ^b,c   Udayakumar, Krishna ^a   Califf, Robert M ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY   (United States)

^d Gilead Pharmaceuticals   (United States)

^e DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Biomarkers; Biorepository; Community registry; Disease reclassification; Personalized medicine; Stratified medicine

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; COMMUNITY; DATA ANALYSIS; DISEASE CLASSIFICATION; ELECTRONIC MEDICAL RECORD; HUMAN; MOLECULAR BIOLOGY; PHENOTYPE; PROSPECTIVE STUDY; REGISTER; TRANSLATIONAL RESEARCH; VALIDATION STUDY; VOLUNTEER;

EID: 84865028200     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. CMS. Historical National Health Expenditure Data. 2011; 2012.
2. CBO. The Long Term Outlook for Health Care Spending. 2007; 2012.
3. WHO. The world health report 2000-health systems: improving performance. 2000.
4. OECD. Health at a Glance 2011: OECD Indicator. 2011.
5. Bunnage ME. Getting pharmaceutical R&D back on target. Nat Chem Biol 2011; 7: 335-339.
6. PhRMA. PhRMA 2011 Profile. 2011; 2012.
7. Hood L and Friend SH. Predictive, personalized, preventive, participatory (P4) cancer medicine. Nat Rev Clin Oncol 2011; 8: 184-187.
8. Ginsburg GS and Willard HF. Genomic and personalized medicine: foundations and applications. Transl Res 2009; 154: 277-287.
9. Carlson B. P4 could transform healthcare, but payers and physicians are not yet convinced. Biotechnol Healthc 2010; 7: 7-8.
10. Moving toward precision medicine. Lancet 2011; 378: 1678.
11. Guttmacher AE and Collins FS. Welcome to the genomic era. N Engl J Med 2003; 349: 996-998.
12. Shah SH, Granger CB, Hauser ER, Kraus WE, Sun JL, Pieper K, Nelson CL, Delong ER, Califf RM and Newby LK. Reclassification of cardiovascular risk using integrated clinical and molecular biosignatures: design of and rationale for the Measurement to Understand the Reclassification of Disease of Cabarrus and Kannapolis (MURDOCK) Horizon 1 Cardiovascular Disease Study. Am Heart J 2010; 160: 371-379e2.
13. Patel K, Lucas JE, Thompson JW, Dubois LG, Tillmann HL, Thompson AJ, Uzarski D, Califf RM, Moseley MA, Ginsburg GS, McHutchison JG and McCarthy JJ. High predictive accuracy of an unbiased proteomic profile for sustained virologic response in chronic hepatitis C patients. Hepatology 2011; 53: 1809-1818.
14. Svetkey LP, Ard JD, Stevens VJ, Loria CM, Young DY, Hollis JF, Appel LJ, Brantley PJ, Kennedy BM, Kumanyika SK, Batch BC, Corsino L, Lien LF and Vollmer WM, for the Weight Loss Maintenance Collaborative Research Group. Predictors of long-Term Weight Loss in Adults With Modest Initial Weight Loss, by Sex and Race. Obesity (Silver Spring) 2011.
15. Kraus VB, Feng S, Wang S, White S, Ainslie M, Brett A, Holmes A and Charles HC. Trabecular morphometry by fractal signature analysis is a novel marker of osteoarthritis progression. Arthritis Rheum 2009; 60: 3711-3722.
16. Cyr DD, Lucas JE, Thompson JW, Patel K, Clark PJ, Thompson A, Tillmann HL, McHutchison JG, Moseley MA and McCarthy JJ. Characterization of serum proteins associated with IL28B genotype among patients with chronic hepatitis C. PLoS One 2011; 6: e21854.
17. Williams RS, Casey PJ, Kamei RK, Buckley EG, Soo KC, Merson MH, Krishnan RK and Dzau VJ. A global partnership in medical education between Duke University and the National University of Singapore. Acad Med 2008; 83: 122-127.
18. Ackerly DC, Udayakumar K, Taber R, Merson MH and Dzau VJ. Perspective: global medicine: opportunities and challenges for academic health science systems. Acad Med 2011; 86: 1093-1099.
19. http://today.duke.edu/2010/01/kunshan.html
20. Sim I, Carini S, Tu S, Wynden R, Pollock BH, Mollah SA, Gabriel D, Hagler HK, Scheuermann RH, Lehmann HP, Wittkowski KM, Nahm M and Bakken S. The human studies database project: federating human studies design data using the ontology of clinical research. AMIA Summits Transl Sci Proc 2010; 2010: 51-55.
21. Blumenthal D. Stimulating the adoption of health information technology. N Engl J Med 2009; 360: 1477-1479.
22. HHS. HealthIT. hhs. gov: Southern Piedmont Beacon Community. 2012.
23. NRC. Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease. 2011.
24. Butler D. Translational research: crossing the valley of death. Nature 2008; 453: 840-842.
25. Kraus VB, McDaniel G, Worrell TW, Feng S, Vail TP, Varju G and Coleman RE. Association of bone scintigraphic abnormalities with knee malalignment and pain. Ann Rheum Dis 2009; 68: 1673-1679.
26. Addison S, Coleman RE, Feng S, McDaniel G and Kraus VB. Whole-body bone scintigraphy provides a measure of the total-body burden of osteoarthritis for the purpose of systemic biomarker validation. Arthritis Rheum 2009; 60: 3366-3373.
27. Kraus VB, Jordan JM, Doherty M, Wilson AG, Moskowitz R, Hochberg M, Loeser R, Hooper M, Renner JB, Crane MM, Hastie P, Sundseth S and Atif U. The Genetics of Generalized Osteoarthritis (GOGO) study: study design and evaluation of osteoarthritis phenotypes. Osteoarthritis Cartilage 2007; 15: 120-127.
28. Svetkey LP, Stevens VJ, Brantley PJ, Appel LJ, Hollis JF, Loria CM, Vollmer WM, Gullion CM, Funk K, Smith P, Samuel-Hodge C, Myers V, Lien LF, Laferriere D, Kennedy B, Jerome GJ, Heinith F, Harsha DW, Evans P, Erlinger TP, Dalcin AT, Coughlin J, Charleston J, Champagne CM, Bauck A, Ard JD and Aicher K. Comparison of strategies for sustaining weight loss: the weight loss maintenance randomized controlled trial. JAMA 2008; 299: 1139-1148.
29. Tillmann HL, Patel K, Muir AJ, Guy CD, Li JH, Lao XQ, Thompson A, Clark PJ, Gardner SD, McHutchison JG and McCarthy JJ. Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C. J Hepatol 2011; 55: 1195-1200.
30. Rowell J, Thompson AJ, Guyton JR, Lao XQ, McHutchison JG, McCarthy JJ and Patel K. Serum apolipoprotein C-III is independently associated with chronic hepatitis C infection and advanced fibrosis. Hepatol Int 2011.
31. McCarthy JJ, Li JH, Thompson A, Suchindran S, Lao XQ, Patel K, Tillmann HL, Muir AJ and McHutchison JG. Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin. Gastroenterology 2010; 138: 2307-2314.
32. Li JH, Lao XQ, Tillmann HL, Rowell J, Patel K, Thompson A, Suchindran S, Muir AJ, Guyton JR, Gardner SD, McHutchison JG and McCarthy JJ. Interferon-lambda genotype and low serum lowdensity lipoprotein cholesterol levels in patients with chronic hepatitis C infection. Hepatology 2010; 51: 1904-1911.
33. Dawber TR, Meadors GF and Moore FE, Jr. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health Nations Health 1951; 41: 279-281.
34. Palmer LJ. UK Biobank: bank on it. Lancet 2007; 369: 1980-1982.
35. McCarty CA, Chisholm RL, Chute CG, Kullo IJ, Jarvik GP, Larson EB, Li R, Masys DR, Ritchie MD, Roden DM, Struewing JP and Wolf WA. The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genomics 2011; 4: 13.